273 research outputs found
Efficacy of wild medicinal plant extracts against predominant seed-borne fungi of broad bean cultivars
Seed samples of four Egyptian broad bean cultivars were tested for seed-borne fungi. The deep freezing method was used to isolate twelve seed-borne fungi viz., Alternaria alternata, Aspergillus flavus, A. niger, Botrytis fabae, Cladosporium cladosporioides, Fusarium oxysporum, F. solani,, Penicillium italicum, Rhizoctonia solani, Rhizopus stolonifer, Stemphylium globuliferum and Trichothecium roseum from the broad bean cultivars viz., Giza 3, Giza 429, Giza 843 and Misr 1. Aspergillus flavus, Botrytis fabae, Fusarium oxysporum and Penicillium italicum were the most predominant fungal species. Aqueous extracts from five wild medicinal plants (Asclepias sinaica, Farsetia aegyptia, Hypericum sinaicum, Phagnalon sinaicum, and Salvia aegyptiaca) which were collected from the Sinai Peninsula, Egypt were tested against the predominant fungal pathogens. All the aqueous plant extracts significantly inhibited the mycelial growth of these fungi, but the extract of Asclepias sinaica exhibited the strongest antifungal activity. The maximum seed germination rate was observed in infested Giza 843 and minimum in Misr 1. Treating seeds with plant extract of Asclepias sinaica (10%) enhanced the percentage of seed germination of all cultivars in both laboratory and pot experiments. Maximum root and shoot lengths of seedlings were recorded in Giza 843 during fungal infestation or treatment by plant extract. In greenhouse experiment, the aqueous A. sinaica extract reduced disease severity and total pigments but increased total phenolics and fruit yield
Comparative studies on the effect of benomyl on growth and ultrastructureof two isolates of phytophthorainfestans from Egypt
The effect of benomyl as a fungicide on growth rate and ultrastructure of two isolates (P623 and P1319) of Phytophthora infestants is compared. Using different concentrations (50, 100, 200 and 500 ppm) of benomyl caused an inhibition of the mycelial growth of both isolates depending on the degree of concentration. The isolate P1319 was found to be more sensitive to benomyl than the isolate P623. Ultrastructural studies confirmedthese observations. The hyphae of isolate P1319 subjected to 100 and 500 ppm benomyl showed severe changes in the cítoplasm more than isolate P623. The increase of lipid bodies and vacuoles in hyphal cytoplasm of both isolates was the characteristic phenomenon after treatment of benomylparticulary at the concentration of 500 ppm
Ultrastructural studies on Vicia faba and its pathogen Botrytis fabae in response to lithium chloride
Ultrastructural investigations of the effect of lithium chloride on Botrytis fabae and its host, Vicia faba are described. Five concentrations (1, 3, 5, 7, 9 mM) of lithium chloride are chosen in the study. The results indicate that the chlorophyll content of host leaves is not affected at lower concentration (3 mM), whereas the higher concentration (9 mM) decreased the chlorophyll content. These two concentrations caused a pronounced cellular disorganization of B. fabae that ranged from disruption of the wall to marked cytoplasmic degeneration. Inoculated host leaves with B. fabae led to the appearance of more vacuolated cytoplasm, a disorganized membrane system of chloroplast and an increase in number of plastoglobuli. These observations are similar to those of host cells treated with 9 mM of lithium chloride. Host cells are not affected by the concentration of 3 mM. Ultarstructural studies indicate that the lower concentration of lithium chloride can be used as a safe fungicide to control B. fabae without a harmful effect on the host (V. faba)
Evaluation of the effectiveness of ozone as a sanitizer for fish experimentally contaminated with Salmonella sp.
Induction of protein citrullination and auto-antibodies production in murine exposed to nickel
Abstract Citrullination, or the post-translational deimination of polypeptide-bound arginine, is involved in several pathological processes in the body, including autoimmunity and tumorigenesis. Recent studies have shown that nanomaterials can trigger protein citrullination, which might constitute a common pathogenic link to disease development. Here we demonstrated auto-antibody production in serum of nanomaterials-treated mice. Citrullination-associated phenomena and PAD levels were found to be elevated in nanomaterials -treated cell lines as well as in the spleen, kidneys and lymph nodes of mice, suggesting a systemic response to nanomaterials injection, and validated in human pleural and pericardial malignant mesothelioma (MM) samples. The observed systemic responses in mice exposed to nanomaterials support the evidence linking exposure to environmental factors with the development of autoimmunity responses and reinforces the need for comprehensive safety screening of nanomaterials. Furthermore, these nanomaterials induce pathological processes that mimic those observed in Pleural MM, and therefore require further investigations into their carcinogenicity
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.
BACKGROUND: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized GUARD-C cohort investigated baseline predictors of safety-related dose reductions or discontinuations (sr-RD) and their impact on sustained virologic response (SVR) in patients receiving peginterferon alfa/ribavirin in routine practice. METHODS: A total of 3181 HCV-mono-infected treatment-naive patients were assigned to 24 or 48 weeks of peginterferon alfa/ribavirin by their physician. Patients were categorized by time-to-first sr-RD (Week 4/12). Detailed analyses of the impact of sr-RD on SVR24 (HCV RNA <50 IU/mL) were conducted in 951 Caucasian, noncirrhotic genotype (G)1 patients assigned to peginterferon alfa-2a/ribavirin for 48 weeks. The probability of SVR24 was identified by a baseline scoring system (range: 0-9 points) on which scores of 5 to 9 and <5 represent high and low probability of SVR24, respectively. RESULTS: SVR24 rates were 46.1% (754/1634), 77.1% (279/362), 68.0% (514/756), and 51.3% (203/396), respectively, in G1, 2, 3, and 4 patients. Overall, 16.9% and 21.8% patients experienced ≥1 sr-RD for peginterferon alfa and ribavirin, respectively. Among Caucasian noncirrhotic G1 patients: female sex, lower body mass index, pre-existing cardiovascular/pulmonary disease, and low hematological indices were prognostic factors of sr-RD; SVR24 was lower in patients with ≥1 vs. no sr-RD by Week 4 (37.9% vs. 54.4%; P = 0.0046) and Week 12 (41.7% vs. 55.3%; P = 0.0016); sr-RD by Week 4/12 significantly reduced SVR24 in patients with scores <5 but not ≥5. CONCLUSIONS: In conclusion, sr-RD to peginterferon alfa-2a/ribavirin significantly impacts on SVR24 rates in treatment-naive G1 noncirrhotic Caucasian patients. Baseline characteristics can help select patients with a high probability of SVR24 and a low probability of sr-RD with peginterferon alfa-2a/ribavirin.This study was sponsored by F. Hoffmann-La Roche Ltd, Basel, Switzerland. Support for third-party writing
assistance for this manuscript, furnished by Blair Jarvis MSc, ELS, of Health Interactions, was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort
Background: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized GUARD-C cohort investigated baseline predictors of safety-related dose reductions or discontinuations (sr-RD) and their impact on sustained virologic response (SVR) in patients receiving peginterferon alfa/ribavirin in routine practice. Methods: A total of 3181 HCV-mono-infected treatment-naive patients were assigned to 24 or 48 weeks of peginterferon alfa/ribavirin by their physician. Patients were categorized by time-to-first sr-RD (Week 4/12). Detailed analyses of the impact of sr-RD on SVR24 (HCV RNA <50 IU/mL) were conducted in 951 Caucasian, noncirrhotic genotype (G)1 patients assigned to peginterferon alfa-2a/ribavirin for 48 weeks. The probability of SVR24 was identified by a baseline scoring system (range: 0-9 points) on which scores of 5 to 9 and <5 represent high and low probability of SVR24, respectively. Results: SVR24 rates were 46.1 % (754/1634), 77.1% (279/362), 68.0% (514/756), and 51.3% (203/396), respectively, in G1,2, 3, and 4 patients. Overall, 16.9% and 21.8% patients experienced 651 sr-RD for peginterferon alfa and ribavirin, respectively. Among Caucasian noncirrhotic G1 patients: female sex, lower body mass index, pre-existing cardiovascular/pulmonary disease, and low hematological indices were prognostic factors of sr-RD; SVR24 was lower in patients with 651 vs. no sr-RD by Week 4 (37.9% vs. 54.4%; P = 0.0046) and Week 12 (41.7% vs. 55.3%; P = 0.0016); sr-RD by Week 4/12 significantly reduced SVR24 in patients with scores <5 but not 655. Conclusions: In conclusion, sr-RD to peginterferon alfa-2a/ribavirin significantly impacts on SVR24 rates in treatment-naive G1 noncirrhotic Caucasian patients. Baseline characteristics can help select patients with a high probability of SVR24 and a low probability of sr-RD with peginter-feron alfa-2a/ribavirin
Advanced Virgo Plus: Future Perspectives
While completing the commissioning phase to prepare the Virgo interferometer for the next joint Observation Run (O4), the Virgo collaboration is also finalizing the design of the next upgrades to the detector to be employed in the following Observation Run (O5). The major upgrade will concern decreasing the thermal noise limit, which will imply using very large test masses and increased laser beam size. But this will not be the only upgrade to be implemented in the break between the O4 and O5 observation runs to increase the Virgo detector strain sensitivity. The paper will cover the challenges linked to this upgrade and implications on the detector's reach and observational potential, reflecting the talk given at 12th Cosmic Ray International Seminar - CRIS 2022 held in September 2022 in Napoli
The Advanced Virgo+ status
The gravitational wave detector Advanced Virgo+ is currently in the commissioning phase in view of the fourth Observing Run (O4). The major upgrades with respect to the Advanced Virgo configuration are the implementation of an additional recycling cavity, the Signal Recycling cavity (SRC), at the output of the interferometer to broaden the sensitivity band and the Frequency Dependent Squeezing (FDS) to reduce quantum noise at all frequencies. The main difference of the Advanced Virgo + detector with respect to the LIGO detectors is the presence of marginally stable recycling cavities, with respect to the stable recycling cavities present in the LIGO detectors, which increases the difficulties in controlling the interferometer in presence of defects (both thermal and cold defects). This work will focus on the interferometer commissioning, highlighting the control challenges to maintain the detector in the working point which maximizes the sensitivity and the duty cycle for scientific data taking
Frequency-Dependent Squeezed Vacuum Source for the Advanced Virgo Gravitational-Wave Detector
In this Letter, we present the design and performance of the frequency-dependent squeezed vacuum source that will be used for the broadband quantum noise reduction of the Advanced Virgo Plus gravitational-wave detector in the upcoming observation run. The frequency-dependent squeezed field is generated by a phase rotation of a frequency-independent squeezed state through a 285 m long, high-finesse, near-detuned optical resonator. With about 8.5 dB of generated squeezing, up to 5.6 dB of quantum noise suppression has been measured at high frequency while close to the filter cavity resonance frequency, the intracavity losses limit this value to about 2 dB. Frequency-dependent squeezing is produced with a rotation frequency stability of about 6 Hz rms, which is maintained over the long term. The achieved results fulfill the frequency dependent squeezed vacuum source requirements for Advanced Virgo Plus. With the current squeezing source, considering also the estimated squeezing degradation induced by the interferometer, we expect a reduction of the quantum shot noise and radiation pressure noise of up to 4.5 dB and 2 dB, respectively
- …